May. 1 at 10:30 AM
$SXI Q3 '26 Earnings Results & Recap
Standex expects slightly to moderately higher revenue in Q4 FY26, driven by mid-to-high single-digit organic growth and increased new product sales. Standex anticipates slightly lower adjusted operating margin due to growth investments and higher medical costs.